Biotech stories

Iktos and Cube Biotech have partnered to leverage AI-driven drug discovery and advanced protein technology, targeting the Amylin Receptor for cardiometabolic disorders.

New Relic has been named a Leader in the 2024 Gartner Magic Quadrant for Digital Experience Monitoring, praised for its visionary integrations and customer satisfaction.

Hexaware Technologies and PointCross Life Sciences have launched a Clinical Data Automation solution to streamline data management for the BioPharma and BioTech sectors.

Redalpine closes its largest fund to date, the USD $200 million RAC VII, bringing total assets to over USD $1 billion and opens a new office in London.

New Relic has been named a Leader in the Gartner Magic Quadrant for Observability Platforms, continuing its unmatched streak since 2012.

Superlab Suisse opens the largest private lab in Switzerland at Basel's Stcki Park, boosting support for life science and biotech startups with state-of-the-art facilities.

Litmaps, a New Zealand AI tool, has expanded its growth to 370,000 global users, preparing for a Series A to expand its academic reach.

Capgemini's new report reveals a six-fold surge in connected health solutions in pharma and biotech since 2021, with organisations expecting 20% of revenue from these services within five years.

Reveille Software partners with Court Square Group to optimise user experience and efficiency for the life science industry software, RegDocs365, aiming to reduce downtime and swiftly resolve content-related issues.

NZTech unveils a report outlining the crucial role technology may have in cutting emissions and promoting environmental sustainability.

On International Women's Day 2024, women strive for equality in STEM fields, overcoming difficulties, and advocating for their teams, with data indicating a growing desire for career progression.

Kyriba's latest CIR unveils a $30bn FX impact on 1,200 multinational firms in Q3 2023, highlighting FX's influence on revenues and cash flows.

Intix a data management product company appoints Kurt Florus as their new CTO aiming to streamline transaction data processing.

The high content screening market will register positive growth, with the overall valuation forecast to reach US$1.6 billion in 2022, according to FMI.

Sandy Baker appointed independent non-executive director of Stanchion, brings 30+ years experience in finance, governance and impact investing.

Kaspersky launches comprehensive cybersecurity policy to address the security risks posed by human augmentation technology in the workplace.

2020 will go down in history for the year of the global pandemic, but also for the rise of innovative digital technologies.

With New Zealand aiming to make tech our number two export by 2025, and primary industry already our number one, we need a clear path forward.

New Zealand's biotech industry could boost GDP to $182bn in 12 years, says BiotechNZ executive director Dr Zahra Champion.

NZ shares climbed as the NZX 50 Index rose 0.4%, led by Fonterra's rebound from a record low, while Hallenstein Glassons surged 6.5% on robust profit figures.